Market volatility has boosted dividend stocks. These are among Wolfe Research's favorites

4%: Dividend-focused ETFs (ProShares NOBL and Vanguard VYM) are each up ~4% YTD (ex-div) while the S&P 500 is down ~2% YTD as Iran-related oil spikes and AI fears weigh on sentiment. Wolfe Research favors dividend aristocrats in the second-highest yield quintile; examples include Colgate-Palmolive (+14% YTD, 2.39% yield, qtrly dividend raised to $0.53), Johnson & Johnson (+17% YTD, 2.15% yield, strong 2026 guidance and positive Phase 1 trial news), and Fastenal (+13% YTD, 2.11% yield, Feb sales +13.3% and new 900k sq ft logistics hub planned). The note also flags the backdrop of the Fed having last cut rates in Dec and markets pricing further cuts later this year, supporting income-oriented, defensive positioning.

Analysis

Dividend-focused names in the mid-yield quintiles offer an asymmetric payoff: enough payout to anchor total return expectations while leaving room for dividend growth that top-yield names lack. Empirically, these names exhibit lower forward volatility and fewer cuts over 12–36 month horizons, but their performance is conditional on a benign inflation-to-rate path; a sustained oil shock that keeps core inflation >3.5% would materially raise the probability of a policy pause and invert this relationship.

At the company level, legacy consumer staples face secular demand compression that requires operational levers (SKU rationalization, gross-to-net, channel shift) to reaccelerate EPS growth — that creates outcomes with low frequency but high impact on dividend trajectory over 12–24 months. Industrial distributors operate like a high-frequency read on manufacturing activity: early-month shipment and inventory cadence can presage quarter revisions, while logistics capex creates a 12–36 month operating-leverage payoff as hubs scale.

Pharma-like businesses trade on binary clinical/regulatory outcomes layered on durable cash returns; pricing concessions or government linkages improve near-term political risk but compress optionality on pricing power, making implied volatility in options an inexpensive hedge. The key systemic tail is geopolitics: sustained MENA-driven energy tightness shifts the macro path, increasing financing costs for capex-heavy expansions and compressing multiple expansion for previously defensive cash-generative names.

Key Decisions for Investors

• JNJ: Buy a defined-cost bullish structure (6–9 month 12–18% OTM call spread) to capture pipeline and pricing optionality while limiting downside to premium paid; target asymmetric payoff of 2.5x–4x on positive readthroughs, lose premium on negative binary outcomes — position size 1–2% NAV.
• CL: Accumulate on >8% pullback from current levels with a 12-month horizon; overlay a covered-call sleeve (1–2 month OTM calls sold monthly) to enhance yield ~200–300bps annually and set a hard stop-loss at -12% to protect capital if category weakness accelerates.
• FAST: Go long stock into next two quarterly data points (3–9 month horizon) to play manufacturing re-acceleration and capacity leverage; consider a paired trade long FAST / short XLI (or a broad industrial ETF) to isolate share gains — target 10–20% relative outperformance, monitor inventory-to-sales metrics weekly.
• Portfolio: Rotate 1–3% into mid-yield dividend aristocrat cohort (selective names rather than ETF) while hedging macro tail with a 3–6 month Brent call or broad commodity hedge if oil >$85 persists for two consecutive months — this protects against policy-driven reversals.